Characterization of ermB Gene Transposition by Tn 1545 and Tn 917 in Macrolide-Resistant Streptococcus pneumoniae Isolates
Open Access
- 1 January 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (1) , 168-173
- https://doi.org/10.1128/jcm.43.1.168-173.2005
Abstract
In Streptococcus pneumoniae , the ermB gene is carried by transposons, such as Tn 917 and Tn 1545 . This study investigated the relationship between macrolide resistance and the presence of the ermB gene on Tn 917 or Tn 1545 in 84 Japanese pneumococcal isolates. Macrolide-resistant strains were classified into two groups as follows. Group 1 (19 strains) showed a tendency to high resistance to erythromycin (MIC at which 50% of isolates are inhibited, 4 mg/liter; MIC at which 90% of isolates are inhibited [MIC 90 ], 128 mg/liter) but susceptibility to rokitamycin (MIC 90 , 1 mg/liter), with the ermB gene located on Tn 1545 . Group 2 (65 strains) showed a tendency to high resistance to both antibiotics (MIC 90 s for both erythromycin and rokitamycin, >128 mg/liter), with the ermB gene located on Tn 917 . There were no strains with constitutive macrolide resistance in either group. All of the strains in group 2 had a deletion in the promoter region of ermB and an insertion of the TAAA motif in the leader peptide. The results of pulsed-field gel electrophoresis and serogrouping showed that Tn 1545 spread clonally while Tn 917 spread both horizontally and clonally. In conclusion, in Japanese macrolide-resistant S. pneumoniae isolates, the ermB gene is carried and spread primarily by Tn 917 .Keywords
This publication has 28 references indexed in Scilit:
- Induction of telithromycin resistance in Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 2003
- Macrolide‐Resistant Pneumococcal Endocarditis and Epidural Abscess that Develop during Erythromycin TherapyClinical Infectious Diseases, 2003
- Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2002
- Ribosomal Mutations in Streptococcus pneumoniae Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2002
- Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2002
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- The Emergence ofStreptococcus pneumoniaeResistant to Macrolide Antimicrobial Agents: A 6‐Year Population‐Based AssessmentThe Journal of Infectious Diseases, 2000
- Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide PassageAntimicrobial Agents and Chemotherapy, 2000
- Induction of Ribosome Methylation in MLS-ResistantStreptococcus pneumoniaeby Macrolides and KetolidesMicrobial Drug Resistance, 1999
- Antimicrobial Resistance in Streptococcus pneumoniae: An OverviewClinical Infectious Diseases, 1992